Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
Patients homozygous for the D90A mutation of the SOD1 gene (homD90A) demonstrate markedly slower progression of disease than those patients with sporadic ALS (SALS). PET studies have demonstrated a different cortical vulnerability in the two groups, reflected also in neurophysiological studies showi...
主要な著者: | Turner, M, Hammers, A, Allsop, J, Al-Chalabi, A, Shaw, C, Brooks, D, Leigh, P, Andersen, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.
著者:: Turner, M, 等
出版事項: (2007) -
Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
著者:: Wicks, P, 等
出版事項: (2005) -
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
著者:: Wicks, P, 等
出版事項: (2008) -
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
著者:: Turner, M, 等
出版事項: (2002) -
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
著者:: Turner, M, 等
出版事項: (2005)